Tomotaka Yazaki, K. Kawashima, N. Ishimura, Masatoshi Kataoka, Mai Fukunaga, R. Hyakudomi, Y. Tajima, I. Moriyama, A. Araki, K. Kadota, Kotaro Shibagaki, Hiroshi Tobita, S. Ishihara
{"title":"奥沙利铂相关性门脉高压合并食管静脉曲张和难治性大量腹水","authors":"Tomotaka Yazaki, K. Kawashima, N. Ishimura, Masatoshi Kataoka, Mai Fukunaga, R. Hyakudomi, Y. Tajima, I. Moriyama, A. Araki, K. Kadota, Kotaro Shibagaki, Hiroshi Tobita, S. Ishihara","doi":"10.2169/internalmedicine.9266-21","DOIUrl":null,"url":null,"abstract":"Oxaliplatin, widely used as a chemotherapy drug for colorectal cancer, is known to cause various adverse reactions. In particular, special attention for the development of portal hypertension associated with porto-sinusoidal vascular disease is necessary, as it is a serious adverse life-threating reaction, although rare. We herein report a case of oxaliplatin-related portal hypertension that developed several years after oxaliplatin administration and led to esophageal varices and refractory massive ascites. Clinical physicians should be aware of the possibility of oxaliplatin-induced portal hypertension and its possible development over a long period after discontinuation of the drug.","PeriodicalId":77259,"journal":{"name":"Medicina interna (Bucharest, Romania : 1991)","volume":"61 1","pages":"3225 - 3231"},"PeriodicalIF":0.0000,"publicationDate":"2022-04-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"2","resultStr":"{\"title\":\"Oxaliplatin-related Portal Hypertension Complicated with Esophageal Varices and Refractory Massive Ascites\",\"authors\":\"Tomotaka Yazaki, K. Kawashima, N. Ishimura, Masatoshi Kataoka, Mai Fukunaga, R. Hyakudomi, Y. Tajima, I. Moriyama, A. Araki, K. Kadota, Kotaro Shibagaki, Hiroshi Tobita, S. Ishihara\",\"doi\":\"10.2169/internalmedicine.9266-21\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Oxaliplatin, widely used as a chemotherapy drug for colorectal cancer, is known to cause various adverse reactions. In particular, special attention for the development of portal hypertension associated with porto-sinusoidal vascular disease is necessary, as it is a serious adverse life-threating reaction, although rare. We herein report a case of oxaliplatin-related portal hypertension that developed several years after oxaliplatin administration and led to esophageal varices and refractory massive ascites. Clinical physicians should be aware of the possibility of oxaliplatin-induced portal hypertension and its possible development over a long period after discontinuation of the drug.\",\"PeriodicalId\":77259,\"journal\":{\"name\":\"Medicina interna (Bucharest, Romania : 1991)\",\"volume\":\"61 1\",\"pages\":\"3225 - 3231\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2022-04-02\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"2\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Medicina interna (Bucharest, Romania : 1991)\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.2169/internalmedicine.9266-21\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Medicina interna (Bucharest, Romania : 1991)","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2169/internalmedicine.9266-21","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Oxaliplatin-related Portal Hypertension Complicated with Esophageal Varices and Refractory Massive Ascites
Oxaliplatin, widely used as a chemotherapy drug for colorectal cancer, is known to cause various adverse reactions. In particular, special attention for the development of portal hypertension associated with porto-sinusoidal vascular disease is necessary, as it is a serious adverse life-threating reaction, although rare. We herein report a case of oxaliplatin-related portal hypertension that developed several years after oxaliplatin administration and led to esophageal varices and refractory massive ascites. Clinical physicians should be aware of the possibility of oxaliplatin-induced portal hypertension and its possible development over a long period after discontinuation of the drug.